glp 1 average weight loss Research Recap: GLP-1 Access & Clinical Outcomes for Obesity Treatment | Calibrate Gastric Sleeve vs GLP-1 Weight
Description
As the GLP-1 product market continues to expand, manufacturers must find ways to differentiate their inline and pipeline assets with new evidence and strong value story.
A retrospective analysis of more than 110,000 women between the ages of 45 and 80 found that those who take GLP-1 medications are about 30% less likely to develop breast cancer than those who do not take GLP-1 medications.
Where the field goes next The EVOKE/EVOKE+ results reinforce that singlemechanism interventions may not be sufficient to modify Alzheimers course in symptomatic stages
drugs like Ozempic).
